Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02163941 · ClinicalTrials.gov registry record · Phase 1

Meditation for Emotional Numbing in Post-Traumatic Stress Disorder

A Phase 1 study, sponsored by Emory University.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target

NCT02163941: Completed Phase 1 study, sponsored by Emory University.

NCT02163941 is a Phase 1 study that has completed, run by Emory University. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02163941, a Phase 1 study, has completed, sponsored by Emory University.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target

Study Summary

For individuals suffering from posttraumatic stress disorder (PTSD), the emotional numbing and isolation that are a core aspect of their suffering and consistently impedes remediation often remains after first-line treatments are administered. Few interventions have proven successful for enhancing the empathy and social connectedness that will ultimately allow patients to flourish, and the search for target therapies is made more difficult by the fact that very little is known about the underlying physiology of emotional numbing and social isolation. The proposed study is designed to (1) investigate the hormonal, neural and immunological biomarkers related to emotional numbing, and (2) test whether cognitively-based compassion training (CBCT), an intervention designed and proven to enhance empathy, will reduce emotional numbing and increase empathy and social connectedness in veterans. To this end, thirty medically healthy males diagnosed with PTSD who continue to report emotional numbing symptoms after prolonged exposure therapy will receive 8 weeks of training in CBCT. Prior to, and again after the training, the investigators will assess patients' levels of oxytocin, inflammation, and self-reported emotional numbing and social connectedness. The investigators will also assess their neural response during a video task that assesses their ability to accurately read others' emotions. The investigators hypothesize that oxytocin, neural activity, and inflammation will predict social numbing, isolation, and empathy, and also that CBCT will positively impact the social outcomes that will pave the way toward health and well-being.

Primary Outcome

Self-report questionnaire assessment of social connectedness

Interventions

  • BEHAVIORAL Compassion Training

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2014-05
Est. Completion 2016-05
Phase Phase 1
Emory University

1,208 total trials

What the finished NCT02163941 record still lists

NCT02163941 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).

The record links to 0 conditions, and to 1 intervention - of which Compassion Training is the first listed.

NCT02163941 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02163941 about?

NCT02163941 is a clinical study titled "Meditation for Emotional Numbing in Post-Traumatic Stress Disorder". For individuals suffering from posttraumatic stress disorder (PTSD), the emotional numbing and isolation that are a core aspect of their suffering and consistently impedes remediation often remains after first-line treatments are administered. Few interventions have proven successful for enhancing t...

What is the current status of trial NCT02163941?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2014-05. Estimated completion is 2016-05.

What interventions are being tested in trial NCT02163941?

The interventions under investigation include: Compassion Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02163941?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02163941's enrollment target sits among peer trials

20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02163941, the US trial registry maintained by the National Library of Medicine. NCT02163941 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.